Barnes P J
Dept of Thoracic Medicine, National Heart and Lung Institute, London, UK.
Eur Respir J. 1995 Mar;8(3):457-62. doi: 10.1183/09031936.95.08030457.
The cyclic nucleotides, cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) play an important role in the regulation of airway smooth muscle tone and activation of inflammatory cells. Intracellular concentrations of these nucleotides are tightly regulated by phosphodiesterases (PDEs). Several families of PDEs are now recognized and, within each isoenzyme family, molecular cloning has revealed multiple members. PDE III and IV are important in the breakdown of cAMP; PDE III is involved in the regulation of airway smooth muscle tone, whereas PDE IV is more important in inflammatory cells, including mast cells, macrophages, eosinophils, T-lymphocytes and epithelial cells. PDE V is involved in the breakdown of cGMP in airway and vascular smooth muscle. Regulation of PDE expression in health and disease is now under investigation. Several selective PDE inhibitors have recently been developed, and experimental studies indicate that PDE IV inhibitors may be useful as anti-inflammatory treatments in asthma. Clinical trials in asthma are now in progress.
环核苷酸,即环磷酸腺苷(cAMP)和环磷酸鸟苷(cGMP),在气道平滑肌张力调节及炎症细胞激活过程中发挥着重要作用。这些核苷酸的细胞内浓度受到磷酸二酯酶(PDEs)的严格调控。目前已确认有几个磷酸二酯酶家族,并且在每个同工酶家族中,分子克隆已揭示出多个成员。磷酸二酯酶III和IV在cAMP的分解中起重要作用;磷酸二酯酶III参与气道平滑肌张力的调节,而磷酸二酯酶IV在包括肥大细胞、巨噬细胞、嗜酸性粒细胞、T淋巴细胞和上皮细胞在内的炎症细胞中更为重要。磷酸二酯酶V参与气道和血管平滑肌中cGMP的分解。目前正在研究健康和疾病状态下磷酸二酯酶表达的调控。最近已开发出几种选择性磷酸二酯酶抑制剂,实验研究表明,磷酸二酯酶IV抑制剂可能作为哮喘的抗炎治疗药物有用。目前哮喘的临床试验正在进行中。